Wee1 inhibition is also effective in patient‐derived sarcoma cells; MK1775 as a single agent causes significant apoptotic cell death, suggesting that Wee1 inhibition may represent a novel approach in the treatment of sarcomas. Here, WEE1 is linked to sarcoma.